Scott Isaacs on Muck Rack

Scott Isaacs

Verified
Boston
As seen in: WFXT-TV (Boston, MA), Nature, Frontline Gastroenterology, Vox, Medscape, SHAPE, The Lancet, Endocrine Today, Healio, Healio Cardiology, Healio Gastroenterology and
News Director @Boston25 — Orangeman — Long suffering @Mets fan — Cat Guy — Opinions are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Scott

Contact Scott, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Retatrutide induces ‘impressive’ weight loss of up to 28.3% for adults with obesity

|
By Michael Monostra , Erik Swain , Scott Isaacs 
| Citeline
Key takeaways: Retatrutide was tied to weight loss ranging from 19% with a 4 mg dose to 28.3% with a 12 mg dose at 80 weeks. Of those receiving 12 mg of the drug, 45.3% had a 30% or greater weight loss at 80 weeks. A once-weekly triple receptor agonist conferred up to 28.3% weight loss at 80 weeks for adults with overweight or obesity, according to topline results from a phase 3 trial.
Open in Who Shared Issue with article?

Breaking the ‘Watch and Wait’ Model in Prediabetes Care, With Scott Isaacs, MD

|
By Scott Isaacs 
| consultantlive.com
Prediabetes has long occupied a gray zone in clinical care, frequently identified but often under-addressed. Traditionally viewed as a precursor to type 2 diabetes warranting monitoring rather than immediate action, this approach is increasingly being challenged by a growing recognition of the broader cardiometabolic risks associated with early dysglycemia.
Open in Who Shared View Duplicates (2) Issue with article?

PCOS and MASLD increase cardiometabolic risk for young women

|
By Michael Monostra , Richard Smith, Scott Isaacs 
| Citeline
Key takeaways: Women diagnosed with PCOS and MASLD as adolescents had higher BMI and liver enzymes than healthy women. The presence of both PCOS and MASLD was tied to more than ninefold higher odds for insulin resistance. Girls who develop polycystic ovary syndrome and metabolic dysfunction-associated steatotic liver disease as adolescents have increased risk for adverse cardiometabolic outcomes as adults, according to study findings.
Open in Who Shared Issue with article?
See all 22 licensed articles (25 Total)

Actions

Share this page

Get in touch with Scott

Contact Scott, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified